Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

BACKGROUND: Growth impairment remains common in children with chronic kidney disease (CKD). Available literature indicates low level of recombinant human growth hormone (rhGH) utilization in short children with CKD. Despite efforts at consensus guidelines, lack of high-level evidence continues to co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Nephrol
Main Authors: Akchurin, Oleh M., Kogon, Amy J., Kumar, Juhi, Sethna, Christine B., Hammad, Hoda T., Christos, Paul J., Mahan, John D., Greenbaum, Larry A., Woroniecki, Robert
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450116/
https://ncbi.nlm.nih.gov/pubmed/28558814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0599-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares